Former Generic Executive Indicted For Price Fixing, Bid Rigging
PHILADELPHIA — A former vice president at a New York generic drug manufacturer was indicted Feb. 4 for making a false statement and violating the federal antitrust law by conspiring to...To view the full article, register now.
Already a subscriber? Click here to view full article